Onderzoeker
Marie Truyens
- Trefwoorden (Ghent University):Inflammatory bowel disease
- Disciplines (Flanders Institute for Biotechnology):Analyse van next-generation sequence data, Adaptieve immunologie, Bacteriologie
- Disciplines (Ghent University):Gastro-enterologie
- Zie ook: Marie Truyens (Vlaams Instituut voor Biotechnologie)
Affiliaties
- Vandenbroucke Lab (Onderzoeksgroep)
Lid
Vanaf1 okt 2019 → 31 dec 2022 - Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf1 okt 2018 → 24 sep 2023 - Kenniscentrum voor de Gezondheidszorg Gent (Administratieve eenheid)
Lid
Vanaf15 dec 2014 → 31 dec 2014
Projecten
1 - 1 of 1
- Globale analyse van darm-hersen communicatie tijdens chronische darminflammatieVanaf15 nov 2019 → 30 sep 2022Financiering: BOF - doctorale mandaten
Publicaties
1 - 10 van 32
- Idiopathic thrombocytopaenic purpura associated with inflammatory bowel disease : a multicentre ECCO CONFER case series(2023)
Auteurs: Hussein Mahajna, Bram Verstockt, Daniel Bergemalm, Fabiana Castiglione, Fransisco Rodríguez-Moranta, Edoardo Savarino, Frank Hoentjen, Talat Bessissow, Jagoda Pokryszka, Anneline Cremer, et al.
Pagina's: 722 - 727 - Editorial : LAG‐3‐depleting monoclonal antibody : a potential treatment for patients with ulcerative colitis?(2023)
Auteurs: Triana Lobatón Ortega, Marie Truyens
Pagina's: 359 - 360 - Comparison of short- and long-term effectiveness between anti-TNF and ustekinumab after vedolizumab failure as first-line therapy in Crohn’s disease : a multi-center retrospective cohort study(2023)
Auteurs: Ahmad Albshesh, Lian Bannon, Tali Sharar Fischler, Marie Truyens, Stephan R. Vavricka, Katja Tepes, Daniela Pugliese, Edoardo V. Savarino, Eran Zittan, David Drobne, et al.
- SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders : a prospective, real-life Belgian cohort study - the BELCOMID study(2023)
Auteurs: Jeroen Geldof, Marie Truyens, João Sabino, Marc Ferrante, Jo Lambert, Hilde Lapeere, Tom Hillary, An Van Laethem, Kurt de Vlam, Patrick Verschueren, et al.
- Significant differences in IBD care and education across Europe : results of the pan-European VIPER survey(2023)
Auteurs: Jan Kral, Radislav Nakov, Vera Lanska, Brigida Barberio, Nicolas Benech, Andreas Blesl, Eduard Brunet, Tiago Capela, Lauranne Derikx, Gabriele Dragoni, et al.
Pagina's: 387 - 395 - Autoimmune pancreatitis in patients with inflammatory bowel disease : a real-world multicentre collaborative ECCO CONFER study(2023)
Auteurs: Piotr Eder, Bram Verstock, Emma Culver, Gabriele Dragoni, Lea Isabell Kredel, Joanna Wypych, Ana Garcia Garcia de Paredes, Magdalena Kaniewska, Haim Leibovitzh, Triana Lobatón Ortega, et al.
Pagina's: 1791 - 1799 - A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)(2022)Volume: 16
Auteurs: Marie Truyens, Triana Lobatón Ortega, Anneleen Peeters, Marc Ferrante, Séverine Vermeire, Peter Bossuyt, Lieven Pouillon, Pieter Dewint, Anneline Cremer, Harald Peeters, et al.
Pagina's: i029 - i032 - The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study(2022)
Auteurs: Cara De Galan, Marie Truyens, Harald Peeters, Francisco Mesonero Gismero, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocio Ferreiro- Iglesias, Tom Holvoet, et al.
Pagina's: 1676 - 1686 - Infliximab re-challenge : could it be an option in refractory IBD patients?(2022)Volume: 16
Auteurs: Marie Truyens, Eva Pijoan Comas, ELIEN GLORIEUS, Jeroen Geldof, Triana Lobatón Ortega
Pagina's: i315 - i316 - Gastroenteropancreatic neuroendocrine neoplasms in patients with inflammatory bowel fisease : an ECCO CONFER multicentre case series(2022)
Auteurs: Stefano Festa, Giulia Zerboni, Lauranne A A P Derikx, Davide Giuseppe Ribaldone, Gabriele Dragoni, Christianne Buskens, Els Nieveen van Dijkum, Daniela Pugliese, Francesco Panzuto, Iwona Krela-Kazmierczak, et al.
Pagina's: 940 - 945